BBI-4000 Gel, 5% + BBI-4000 Gel, 10% + BBI-4000 Gel, 15% + Vehicle

Phase 2Completed
0 watching 0 views this week Active
44
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hyperhidrosis

Conditions

Hyperhidrosis

Trial Timeline

Mar 10, 2015 → Nov 5, 2015

About BBI-4000 Gel, 5% + BBI-4000 Gel, 10% + BBI-4000 Gel, 15% + Vehicle

BBI-4000 Gel, 5% + BBI-4000 Gel, 10% + BBI-4000 Gel, 15% + Vehicle is a phase 2 stage product being developed by Botanix Pharmaceuticals for Hyperhidrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02336503. Target conditions include Hyperhidrosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02336503Phase 2Completed

Competing Products

14 competing products in Hyperhidrosis

See all competitors